Bausch Health - M&A Summary and Business Overview

Life ScienceCompany

Bausch Health M&A Summary

Bausch Health has acquired 40 companies, including 2 in the last 5 years. A total of 13 acquisitions came from private equity firms. It has also divested 10 assets.

Bausch Health’s largest acquisition to date was in 2015, when it acquired Salix Pharmaceuticals for $14.5B. It’s largest disclosed sale occurred in 2017, when it sold iNova Pharmaceuticals Pty to Pacific Equity Partners for $930M. Bausch Health has acquired in 10 different US states, and 11 countries. The Company’s most targeted sectors include life science (60%) and consumer products (18%).

Bausch Health Business Overview

Where is Bausch Health headquartered?

Bausch Health is headquartered in Laval, Quebec.

What is Bausch Health’s revenue?

Bausch Health disclosed revenue of 8,124M USD for 2022 and 8,434M USD for 2021.

How many employees does Bausch Health have?

Bausch Health has 19,900 employees.

What sector is Bausch Health in?

Bausch Health is a life science company.

M&A Summary

  • M&A Total Activity45
    • M&A Buy Activity35
    • M&A Sell Activity10
  • Total Sectors Invested 4
  • Total Countries Invested 11
  • M&A Buy/Sell Connections 34
  • M&A Advisors 17

Bausch Health

Bausch Health Companies, Inc.

2150 St. Elzéar Boulevard West,
Laval, Quebec H7L 4A8
Canada,
(514) 744-6792
www.bauschhealth.com

Bausch Health is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology, and branded generics. Bausch Health is based in Laval, Quebec.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.2/yr) # 34 1 - - - - 35
vol $32.8B $32.8B
Sell (0.2/yr) # 9 - 1 - - - 10
vol $2.0B $740M $2.7B
  45

Most Recent M&A

Company Date Value Type
Amoun Pharmaceutical Company S.A.E. 2021-03-31 740M USD Divestiture
Cairo, Egypt · www.amoun.com
Allegro Ophthalmics LLC - Ophthalmology Assets 2020-09-21 - Divestiture
San Juan Capistrano, California
Synergy Pharmaceuticals, Inc. - Certain Assets 2019-02-26 195M USD Divestiture
New York, New York
Obagi Medical Products, Inc. 2017-11-10 190M USD Divestiture
Long Beach, California · www.obagi.com
iNova Pharmaceuticals (Australia) Pty Ltd. 2017-06-08 930M USD Divestiture
Chatswood, Australia · www.inovapharma.com
CeraVe 2017-01-10 - Divestiture
Bridgewater, New Jersey · www.cerave.com
Acnefree 2017-01-10 - Divestiture
Bridgewater, New Jersey · www.acnefree.com
Valeant Pharmaceuticals - AMBI Skincare 2017-01-10 - Divestiture
Bridgewater, New Jersey
Dendreon Pharmaceuticals, Inc. 2017-01-09 820M USD Divestiture
Seattle, Washington · www.dendreon.com
Synergetics USA, Inc. 2015-10-15 - Add-on Acquisition
O’Fallon, Montana · www.synergeticsusa.com
View All >>

Business Unit M&A

Company Acquired Add-On/Sale Date #
Bausch & Lomb, Inc. 2013-05-27 Xiidra 2023-06-30 3
Rochester, New York · www.bausch.com Basel, Switzerland · www.xiidra.com
Bausch & Lomb, Inc. 2013-05-27 Acufocus, Inc. 2023-01-17 2
Rochester, New York · www.bausch.com Irvine, California · www.acufocus.com
Bausch & Lomb, Inc. 2013-05-27 Allegro Ophthalmics LLC - Ophthalmology Assets 2020-09-21 1
Rochester, New York · www.bausch.com San Juan Capistrano, California
Synergetics USA, Inc. 2015-10-15 Synergetics USA, Inc. - Neuro Portfolio 2016-02-10 1
O’Fallon, Montana · www.synergeticsusa.com O’Fallon, Montana

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 21 (60%) 21.8B (66%) 3 (30%) 1.7B (64%)
Consumer Products 6 (17%) 782M (2%) 5 (50%) 190M (7%)
Medical Products 6 (17%) 10.2B (31%) 1 (10%) 740M (27%)
Healthcare Services 2 (6%) 20M (< 1%) - -
Technology Hardware - - 1 (10%) 49M (2%)
Total 35 $32.8B 10 $2.7B

By Geo

State/Country Buy Value Sell Value
United States 22 30.6B 7 1.1B
  California 6 1.3B 2 239M
  New Jersey 5 1.1B 3 -
  New York 3 8.9B - -
  North Carolina 2 15.5B - -
  Washington 1 400M 1 820M
  Montana 1 - - -
  Florida 1 28M - -
  Arizona 1 2.6B - -
  Rhode Island 1 475M - -
  Pennsylvania 1 312M - -
Australia 2 498M 1 930M
Canada 3 9M - -
  Ontario 2 9M - -
  Quebec 1 - - -
Egypt 1 800M 1 740M
Austria 1 - - -
Brazil 1 41M - -
India - - 1 -
Lithuania 1 - - -
Mexico 1 - - -
Russia 1 163M - -
Switzerland 1 394M - -
United Kingdom 1 300M - -
Domestic 3 (9%) 9M (< 1%) - -
Cross-border 32 (91%) 32.8B (100%) 10 (100%) 2.7B (100%)
Total 35 $32.8B 10 $2.7B

Top M&A Advisors

Financial Deals
Morgan Stanley
2
Goldman Sachs
2
Centerview Partners
1
Legal Deals
Skadden, Arps, Slate, Meagher & Flom
6
Sullivan & Cromwell
3
Wachtell, Lipton, Rosen & Katz
2

Deal Values

buy # Total
> $1B 4 $26.8B
$100M to $1B 16 $5.8B
< $100M 7 $215M
TOTAL $32.8B
Largest Salix Pharmaceuticals Ltd.
$14.5B (2015-02-22)
sell # Total
$100M to $1B 4 $2.7B
< $100M 1 $49M
TOTAL $2.7B
Largest iNova Pharmaceuticals (Australia) Pty Ltd.
$930M (2017-06-08)

M&A Connections

Deals
Acquired from
Investor(s)
23%
8 (23%)
Strategic(s)
29%
10 (29%)
Divested to
Investor(s)
30%
3 (30%)
Strategic(s)
70%
7 (70%)

 Subscribe to unlock this and 201,455
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.